Featured Research

from universities, journals, and other organizations

Intestinal immune response

Date:
May 10, 2010
Source:
American Journal of Pathology
Summary:
Researchers have found that development of intestinal lymphoid follicles (ILFs) is dependent on dendritic cell recruitment.

Researchers led by Dr. Rodney D. Newberry at the University of Washington, St. Louis, MO have found that development of intestinal lymphoid follicles (ILFs) is dependent on dendritic cell recruitment. They report their data in the May 2010 issue of The American Journal of Pathology.

Lymphoid tissues such as lymph nodes both host immune cells and serve as filters or traps for foreign and infectious antigens. These tissues are fully formed at birth. One type of lymphoid tissue, ILFs, is instrumental in the immune response against intestinal pathogens. However, in contrast to other lymphoid tissues, ILFs are induced by environmental stimuli from microorganisms in the intestinal lumen. Indeed, the formation of these tissues is fully reversible.

In an effort to further understand the development of ILFs, McDonald et al discovered that intestinal microbes recruited clusters of dendritic cells, immune cells that present antigen to other cells, to ILFs. Moreover, depletion of these immune cells resulted in regression of ILFs. Indeed, ILF differentiation was dependent on the cell-migration molecule CXCL13, which is expressed by ILF dendritic cells. Taken together, these data indicate that dendritic cell recruitment plays a key role in ILF development and function, perhaps through the secretion of CXCL13.

Dr. Newberry's group "suggest[s] that like other cellular components of [solitary intestinal lymphoid tissues], [dendritic cells] perform dual functions by shaping their microenvironment and generating immune responses."


Story Source:

The above story is based on materials provided by American Journal of Pathology. Note: Materials may be edited for content and length.


Journal Reference:

  1. McDonald KG, McDonough JS, Dieckgraefe BK, Newberry RD. Dendritic Cells Produce CXCL13 and Participate in the Development of Murine Small Intestine Lymphoid Tissues. American Journal Of Pathology, 2010; 176 (5): 2367 DOI: 10.2353/ajpath.2010.090723

Cite This Page:

American Journal of Pathology. "Intestinal immune response." ScienceDaily. ScienceDaily, 10 May 2010. <www.sciencedaily.com/releases/2010/05/100510141340.htm>.
American Journal of Pathology. (2010, May 10). Intestinal immune response. ScienceDaily. Retrieved September 1, 2014 from www.sciencedaily.com/releases/2010/05/100510141340.htm
American Journal of Pathology. "Intestinal immune response." ScienceDaily. www.sciencedaily.com/releases/2010/05/100510141340.htm (accessed September 1, 2014).

Share This




More Health & Medicine News

Monday, September 1, 2014

Featured Research

from universities, journals, and other organizations


Featured Videos

from AP, Reuters, AFP, and other news services

We've Got Mites Living In Our Faces And So Do You

We've Got Mites Living In Our Faces And So Do You

Newsy (Aug. 30, 2014) A new study suggests 100 percent of adult humans (those over 18 years of age) have Demodex mites living in their faces. Video provided by Newsy
Powered by NewsLook.com
Liberia Continues Fight Against Ebola

Liberia Continues Fight Against Ebola

AFP (Aug. 30, 2014) Authorities in Liberia try to stem the spread of the Ebola epidemic by raising awareness and setting up sanitation units for people to wash their hands. Duration: 00:41 Video provided by AFP
Powered by NewsLook.com
California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

California Passes 'yes-Means-Yes' Campus Sexual Assault Bill

Reuters - US Online Video (Aug. 30, 2014) California lawmakers pass a bill requiring universities to adopt "affirmative consent" language in their definitions of consensual sex, part of a nationwide drive to curb sexual assault on campuses. Linda So reports. Video provided by Reuters
Powered by NewsLook.com
New Drug Could Reduce Cardiovascular Deaths

New Drug Could Reduce Cardiovascular Deaths

Newsy (Aug. 30, 2014) The new drug from Novartis could reduce cardiovascular deaths by 20 percent compared to other similar drugs. Video provided by Newsy
Powered by NewsLook.com

Search ScienceDaily

Number of stories in archives: 140,361

Find with keyword(s):
Enter a keyword or phrase to search ScienceDaily for related topics and research stories.

Save/Print:
Share:

Breaking News:
from the past week

In Other News

... from NewsDaily.com

Science News

Health News

Environment News

Technology News



Save/Print:
Share:

Free Subscriptions


Get the latest science news with ScienceDaily's free email newsletters, updated daily and weekly. Or view hourly updated newsfeeds in your RSS reader:

Get Social & Mobile


Keep up to date with the latest news from ScienceDaily via social networks and mobile apps:

Have Feedback?


Tell us what you think of ScienceDaily -- we welcome both positive and negative comments. Have any problems using the site? Questions?
Mobile: iPhone Android Web
Follow: Facebook Twitter Google+
Subscribe: RSS Feeds Email Newsletters
Latest Headlines Health & Medicine Mind & Brain Space & Time Matter & Energy Computers & Math Plants & Animals Earth & Climate Fossils & Ruins